See the DrugPatentWatch profile for Bexsero
What is the Bexsero vaccine for?
Bexsero is a meningococcal vaccine designed to help protect against invasive meningococcal disease caused by Neisseria meningitidis—specifically meningococcal group B. It is used to reduce the risk of serious illness such as meningitis and bloodstream infection from MenB.
Which age groups can get Bexsero?
Bexsero is used in people where protection against MenB is recommended by local guidance. This commonly includes children, adolescents, and certain higher-risk groups (for example, based on health status or exposure risk). Your country’s immunization schedule determines the exact age and eligibility.
What does the vaccine contain?
Bexsero is a multicomponent MenB vaccine. It uses multiple purified antigens intended to cover key MenB strains by targeting different surface proteins/structures on the bacteria.
How many doses are needed, and when?
The number of doses and timing depend on the person’s age when vaccination starts and local recommendations. Schedules typically differ for infants versus older children/adolescents and may also differ for people vaccinated because of higher risk.
How is it given (shot, site, and boosters)?
Bexsero is given as an injection (a shot), usually into a muscle. Whether boosters are needed depends on age at primary vaccination and local public health guidance, including whether ongoing protection is recommended.
What side effects do people report?
Common side effects after Bexsero are usually short-term and include things like:
- Pain, redness, or swelling where the shot was given
- Fever
- Fatigue or irritability
- Headache or reduced appetite (varies by age)
Serious adverse events are uncommon, but like all vaccines, Bexsero can cause reactions that need medical attention. If you’re deciding for a child or you have a history of vaccine reactions, it’s important to discuss risk and options with a clinician.
Who should not get it, or who should get extra medical advice first?
People should seek medical advice before vaccination if they:
- Have had a serious allergic reaction to a previous dose of Bexsero or to any component
- Have a significant acute illness with fever (vaccination may be delayed)
- Have conditions that affect immune response (clinicians may adjust timing or expectations for protection)
How well does it protect against MenB?
Protection depends on the match between vaccine coverage and circulating strains, and on the age at vaccination. Public health programs use it because it helps reduce MenB disease burden, but no vaccine prevents all cases.
Can someone get Bexsero with other vaccines?
In many immunization schedules, Bexsero is given alongside other routine childhood vaccines, but the exact co-administration plan depends on timing and local guidance. Clinicians can advise based on the child’s vaccine history.
How do people decide between Bexsero and other MenB options?
Some countries offer more than one MenB vaccine formulation. The “best” choice is typically the one recommended in your region for the relevant age group and risk category, and administered according to the approved schedule.
Where can I find the exact schedule for my country?
Dose count, minimum intervals, and eligible age groups are set by national recommendations (and can change). If you tell me your country (and the person’s age), I can help you interpret the typical schedule used there.